BNP PARIBAS FINANCIAL MARKETS - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$5,0000.0%10.0%0.00%
Q2 2021$5,0000.0%10.0%0.00%
Q1 2021$5,000
+25.0%
10.0%0.00%
Q4 2020$4,0000.0%10.0%0.00%
Q3 2020$4,000
-100.0%
1
-100.0%
0.00%
Q2 2020$49,892,000
+140.4%
19,489
+171.4%
0.00%
Q1 2020$20,756,000
-3.0%
7,182
+27.2%
0.00%
Q4 2019$21,406,000
+15.9%
5,648
+56.4%
0.00%
Q3 2019$18,470,000
+18.6%
3,611
+43.8%
0.00%
Q2 2019$15,568,000
-53.0%
2,511
-46.1%
0.00%
Q1 2019$33,111,000
+132.0%
4,657
+553.2%
0.00%
Q3 2018$14,274,000
-22.5%
7130.0%0.00%
Q2 2018$18,417,000
-78.8%
713
-80.4%
0.00%
Q1 2018$86,733,000
-19.4%
3,629
+14.2%
0.00%
Q4 2017$107,669,000
+204.0%
3,177
+89.9%
0.00%
Q3 2017$35,417,000
+13.3%
1,673
-6.4%
0.00%
Q2 2017$31,255,000
+5656.0%
1,787
+5664.5%
0.00%
Q1 2017$543,000
-88.5%
31
-88.9%
0.00%
Q4 2016$4,732,000
-75.4%
280
-76.1%
0.00%
Q3 2016$19,249,000
+94.7%
1,173
+79.6%
0.00%
Q2 2016$9,886,000
-82.9%
653
-68.1%
0.00%
Q4 2015$57,942,000
+67.9%
2,046
-0.7%
0.00%
Q3 2015$34,501,000
+52.1%
2,061
+138.3%
0.00%
Q2 2015$22,680,000
+1752.9%
865
+1135.7%
0.00%
Q1 2015$1,224,000
-28.5%
70
-23.9%
0.00%
Q3 2014$1,713,000920.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,601,351$43,963,0009.03%
Granite Point Capital Management, L.P. 256,031$4,327,0003.45%
Opaleye Management Inc. 285,000$4,817,0002.84%
Brenner West Capital Advisors 1,221,463$20,643,0002.28%
ARMISTICE CAPITAL, LLC 536,000$9,058,0002.14%
NEXTHERA CAPITAL LP 151,670$2,563,0001.50%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 185,234$3,130,0001.41%
Cheyne Capital Management (UK) LLP 144,765$2,448,0001.38%
SPHERA FUNDS MANAGEMENT LTD. 270,000$4,563,0001.16%
Mosaic Family Wealth, LLC 123,314$2,084,0000.96%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders